Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

2012821 citationsJournal Articlegreen Open Access

Authors

Bortezomib during induction and maintenance improves CR and achieves superior PFS and OS.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 30, Issue 24, pp. 2946-2955

Field-Weighted Citation Impact: 53.77